Leucine Rich Bio - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2014, Leucine Rich Bio operates in Health Tech industry. Initially focused on providing genomic diagnostics services, the company has since expanded its offerings to include microbiome test...
Funding stage:
Seed
Last funding:
24/10/2023
Total funding:
$338.45K+
Revenue:
Investors
Employee count:
40
Last 90d
40
Last 90d
Web traffic:
6.79K
6.79K
Last 30d
Last 30d
Glassdoor Rating:
Leucine Rich Bio: Funding Highlights
Funding highlights of Leucine Rich Bio and a snapshot of its key metrics.
Total Funding$338.45K+
Current StageEarly Stage
Total Round(s)3
Funding Rounds
FAQs on Funding of Leucine Rich Bio
Health Tech Funded Leucine Rich Bio has raised a total funding of $338.45K as of 25 October 2023 across 3 rounds. Find the details around funding rounds, participating investors, and other insights of Leucine Rich Bio here...
Leucine Rich Bio has raised a total of $338.45K across 3 funding rounds and the last round was raised on 25 October 2023.
Leucine Rich Bio's key investors include MassChallenge Switzerland.
Leucine Rich Bio's latest funding round was an undisclosed amount in Early Stage, raised on 25 October 2023.
Leucine Rich Bio is at the Early stage. Its most recent round was raised on 25 October 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links